Grants and Contributions:
Title:
Hypothesis Validation for a Point-of-care urinalysis platform for at-home metabolic monitoring
Agreement Number:
964334
Agreement Value:
$50,000.00
Agreement Date:
Jan 15, 2021 - May 31, 2021
Description:
Herstasis Health Inc is developing a clinical Point-of-Care urinalysis invitro medical diagnostic device.
Organization:
National Research Council Canada
Expected Results:
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Location:
New Westminster, British Columbia, CA V3L 2R8
Reference Number:
172-2020-2021-Q4-964334
Agreement Type:
Contribution
Report Type:
Grants and Contributions
Recipient Business Number:
707690939
Recipient Type:
For-profit organization
Additional Information:
This agreement has been amended 1 time(s). The total amended value is 50,000 dollars.
Amendment Date
Mar 29, 2021
Recipient's Legal Name:
Herstasis Health Inc.
Federal Riding Name:
New Westminster--Burnaby
Federal Riding Number:
59019
Program:
Industrial Research Assistance Program – Contributions to Firms
Program Purpose:
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Coverage:
IRAP Contributions to Firms projects stimulate wealth creation for Canada through technological innovation.
NAICS Code:
339110
Amendments: